ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,852,000 | -50.2% | 755,755 | -36.1% | 0.01% | -41.2% |
| Q4 2021 | $47,897,000 | -5.7% | 1,183,521 | -18.8% | 0.02% | -10.5% |
| Q3 2021 | $50,818,000 | +111.2% | 1,457,349 | +66.4% | 0.02% | +111.1% |
| Q2 2021 | $24,056,000 | +7.8% | 876,038 | +10.2% | 0.01% | 0.0% |
| Q1 2021 | $22,319,000 | +17.8% | 794,822 | +8.9% | 0.01% | +12.5% |
| Q4 2020 | $18,951,000 | +51.5% | 730,022 | +0.0% | 0.01% | +33.3% |
| Q3 2020 | $12,512,000 | -27.2% | 730,000 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $17,177,000 | +172.0% | 730,000 | +60.4% | 0.01% | +125.0% |
| Q1 2020 | $6,315,000 | – | 455,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |